AngioDynamics, Inc. (ANGO): Earnings News

ANGO – Misses Wall Street consensus EPS estimates by $0.01 and slightly misses on revenues.

Key Facts Surrounding This News Item

  • ANGO had a POWR Rating of A (Strong Buy) coming into today.
  • ANGO was -0.67% below its 10-Day Moving Average coming into today.
  • ANGO was 0.84% above its 20-Day Moving Average coming into today.
  • ANGO was 7.10% above its 50-Day Moving Average coming into today.
  • ANGO was 15.91% above its 100-Day Moving Average coming into today.
  • ANGO was 23.95% above its 200-Day Moving Average coming into today.
  • ANGO had returned +35.78% year-to-date leading up to today’s news, versus a +5.40% return from the benchmark S&P 500 during the same period.

More Info About AngioDynamics, Inc. (ANGO)

AngioDynamics designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company was founded in 1988 and is based in Latham, New York. View our full ANGO ticker page with ratings, news, and more.

ANGO at a Glance

ANGO Current POWR Rating™
Overall POWR Rating™
ANGO Current Price $23.46 1.34%
More ANGO Ratings, Data, and News

ANGO Price Reaction

The day of this event (Jul. 11, 2018)
ANGO Closing Price$18.95 16.08%
ANGO Volume2,126,200
857.08% from avg
Leading up to this event
ANGO 1-mo return4.97%
After this event
ANGO 1-day return10.15%
ANGO 3-day return8.40%
ANGO 5-day return7.88%

ANGO Price Chart

The Top Stocks For 2019

More AngioDynamics, Inc. (ANGO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ANGO News
Page generated in 0.8174 seconds.